Back to Trades
HOMCY CHARLES J
DirectorCIK 0001192591
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 2
- Active
- 2025–2026
Across 7 filings between 2025–2026, HOMCY CHARLES J, Director, has disclosed $15.2M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $13.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 24 | BBIO BridgeBio Pharma, Inc. | HOMCY CHARLES J | Director | Grant | $363.7K |
| Jun 23 | BBIO BridgeBio Pharma, Inc. | HOMCY CHARLES J | Director | Tax withheld | $52.2K |
| Jun 10 | MAZE Maze Therapeutics, Inc. | HOMCY CHARLES J | Insider | Award | $424.4K |
| Nov 21 | MAZE Maze Therapeutics, Inc. | HOMCY CHARLES J | Insider | Other | $0 |
| Oct 27 | MAZE Maze Therapeutics, Inc. | HOMCY CHARLES J | Insider | Gift | $0 |
| Sep 24 | MAZE Maze Therapeutics, Inc. | HOMCY CHARLES J | Insider | Award | $426.1K |
| Aug 12 | BBIO BridgeBio Pharma, Inc. | HOMCY CHARLES J | Insider | Sell | $13.9M |
7 filings